2m 2m 2m 2m 2m 2m 2m
REGENCELL (RGC)
NASDAQ
$9.88+$0.07 (+0.72%)
Price as of Oct 22, 2026 7:49 PM EDT- N/AMarket Cap
- -38.76%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
REGENCELL (RGC)
$9.88+$0.07 (+0.72%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 6,486 -19.07% | 8,014 -93.61% | 125,427 -52.25% | 262,664 +939.22% | |
Research and Development Expense | -1.3M +37.05% | -948,289 -11.06% | -1.1M -32.59% | -1.6M -37.04% | |
Depreciation and Amortization Expense | 80,908 +4.14% | 77,692 -74.59% | 305,780 +4.31% | 293,135 -35.47% | |
Total Operating Expenses | 11.7M +210.99% | 3.8M -20.41% | 4.7M -24.50% | 6.3M -17.64% | |
Operating Profit | -11.7M +210.99% | -3.8M -20.41% | -4.7M -24.50% | -6.3M -17.64% | |
Interest Income | 22,520 -87.88% | 185,772 -25.09% | 248,000 +190.40% | 85,400 +695.68% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 22,520 -87.88% | 185,772 -25.09% | 248,000 +190.40% | 85,400 +695.68% | |
Total Nonoperating Income and Expense | 22,520 -87.88% | 185,772 -50.26% | 373,505 +76.73% | 211,342 +810.37% | |
Income before Taxes | -11.7M +226.49% | -3.6M -17.85% | -4.4M -28.03% | -6.1M -20.18% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -11.7M +226.49% | -3.6M -16.68% | -4.3M -26.73% | -5.9M -22.69% | |
Net Income from Continuing Operations Applicable to Common | -11.7M +226.49% | -3.6M -17.85% | -4.4M -26.76% | -6.0M -180.01% | |
Basic EPS and Net Income | -2.37 +229.17% | -0.72 +118.18% | -0.33 -173.33% | 0.45 -22.41% | |
Diluted EPS and Net Income | -2.37 +229.17% | -0.72 +118.18% | -0.33 -173.33% | 0.45 -22.41% | |
Basic Weighted Average Shares | 494.6M +0.02% | 494.5M +3,700.00% | 13.0M 0.00% | 13.0M +1.62% | |
Diluted Weighted Average Shares | 494.6M +0.02% | 494.5M +3,700.00% | 13.0M 0.00% | 13.0M +1.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 14.2M +486.68% | 2.4M -18.31% | 3.0M +89.24% | 1.6M -75.61% | |
Short-Term Investments | N/A N/A | 2.5M -50.44% | 5.0M -50.00% | 10.0M 0.00% | |
Cash and Cash Equivalents and Short-Term Investments | 14.2M +189.82% | 4.9M -38.49% | 8.0M -31.16% | 11.6M -29.56% | |
Total Current Assets | 14.2M +190.10% | 4.9M -39.58% | 8.1M -30.18% | 11.6M -29.33% | |
Accumulated Depreciation | 938,959 +9.53% | 857,267 +9.32% | 784,165 +64.68% | 476,164 +155.84% | |
Property and Plant and Equipment and Net | 135,112 -37.28% | 215,434 +52.00% | 141,734 -67.85% | 440,829 -38.14% | |
Total Long-Term Assets | 506,402 -40.62% | 852,769 +163.04% | 324,198 -67.59% | 1.0M -36.45% | |
Total Assets | 14.7M +155.92% | 5.8M -31.79% | 8.4M -33.15% | 12.6M -29.95% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 3.0M N/A | |
Total Current Liabilities | 1.3M +99.00% | 663,673 +242.85% | 193,578 -68.10% | 606,914 +5.05% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 3.3M 0.00% | |
Total Long-Term Liabilities | 59,499 -74.31% | 231,635 +793.17% | 25,934 +2.08% | 25,406 -92.95% | |
Total Liabilities | 1.4M +54.16% | 895,308 +307.86% | 219,512 -65.28% | 632,320 -32.59% | |
Retained Earnings | -36.9M +46.43% | -25.2M +16.58% | -21.6M +24.84% | -17.3M +51.30% | |
Total Stockholders Equity | 13.3M +174.66% | 4.9M -40.86% | 8.2M -31.68% | 12.0M -29.50% | |
Total Shares Outstanding | 495.9M +0.28% | 494.5M +3,700.00% | 13.0M 0.00% | 13.0M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -7.7M +147.16% | -3.1M -22.19% | -4.0M -19.37% | -5.0M -5.77% | |
Capital Expenditures | N/A N/A | 152,689 +2,740.20% | 5,376 -80.37% | 27,392 -96.49% | |
Cash from Investing Activities | 2.5M -6.78% | 2.7M -48.76% | 5.2M +8,789.12% | 58,978 +100.55% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 16.9M N/A | N/A N/A | 102,282 -24.19% | 134,913 -99.40% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -114.25% +126.22% | -50.50% +23.62% | -40.85% +6.60% | -38.32% -53.68% | |
Return on Equity | -128.52% +134.50% | -54.81% +28.99% | -42.49% +5.28% | -40.36% -65.28% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 10.77 +45.78% | 7.39 -82.38% | 41.92 +118.90% | 19.15 -32.72% | |
Cash Ratio | 10.75 +194.82% | 3.65 -76.17% | 15.30 +493.31% | 2.58 -76.79% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.52 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.50 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow